Harper Lee Kaye

Harper Lee Kaye has a diverse work experience in the medical and consulting fields. They started as a Clinical Researcher at Beth Israel Deaconess Medical Center in 2014. In 2015, they became a Research Scientist at Boston Children's Hospital and later took on supervisory roles in the Transcranial Magnetic Stimulation Laboratory. In 2018, they worked as a Doctoral Student at Boston University School of Medicine. In 2019, they became a Principal Consultant at Shepherd Payne Associates. Currently, they hold the position of Head of Product at DVLP Medicines, starting in 2023.

Harper Lee Kaye completed their education in the field of Behavioral Neuroscience with a PhD from Boston University School of Medicine in 2018. Prior to that, they obtained a Bachelor of Science (BS) in Neurobiology and Anatomy from Harvard University in the years 2013-2016. In the period of 2009-2012, Kaye pursued studies in Psychology and Addiction Studies at Syracuse University, although their degree name is unspecified. Additionally, they have obtained various certifications related to their field of expertise, including being a Brainsway Medical Certified Deep TMS Operator and having completed courses in Neuronavigated TMS, Nexstim MRI-based Neuronavigation, and Transcranial Magnetic Stimulation (TMS).